Forschungs- & Entwicklungsinformationsdienst der Gemeinschaft - CORDIS

Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

From 2015-05-20 to 2017-05-19, ongoing project

Project details

Total cost:

EUR 168 277,2

EU contribution:

EUR 168 277,2

Coordinated in:

Italy

Call for proposal:

H2020-MSCA-IF-2014See other projects for this call

Funding scheme:

MSCA-IF-EF-ST - Standard EF

Objective

Related information

Open Access

Coordinator

HUMANITAS MIRASOLE SPA
Italy

EU contribution: EUR 168 277,2


Via Manzoni, 56
20089 ROZZANO-MILAN
Italy
Record Number: 196682 / Last updated on: 2016-05-13